Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
The Overview: September 2024
The Clearity Foundation Joins The OCRA Family A Special Message from OCRA’s President & CEO Dear OCRA Community, Earlier this week, we shared some exciting news as we close out … <a href="https://ocrahope.org/news/the-overview-september-2024/">Continued</a>
Ovarian Cancer Research Alliance Joins with The Clearity Foundation, Strengthening Support for the Ovarian Cancer Community
OCRA to Expand Its Patient Support by Integrating Clearity’s Pioneering Programs. NEW YORK, NY, September 24, 2024 – Ovarian Cancer Research Alliance (OCRA), the world’s largest ovarian cancer nonprofit, is proud to announce that The Clearity Foundation … <a href="https://ocrahope.org/news/ovarian-cancer-research-alliance-joins-with-the-clearity-foundation-strengthening-support-for-the-ovarian-cancer-community/">Continued</a>
Yahoo! Life Highlights OCRA’s Ovarian Cancer Survivors and Supporters Cycling for Research
A new piece published September 6, 2024, on Yahoo! News, is highlighting the impact of Ovarian Cancer Research Alliance’s annual Ovarian Cycle Tampa event. “Ovarian cancer survivors and supporters Cycle … <a href="https://ocrahope.org/news/yahoo-life-highlights-ocras-ovarian-cancer-survivors-and-supporters-cycling-for-research/">Continued</a>